Canada Pension Plan Investment Board’s Vanda Pharmaceuticals VNDA Stock Holding History

Canada Pension Plan Investment Board’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$123K	Sell	20,100 -1,500	-7%	-$9.8K	﹤0.01%	1655
2026 Q1	$149K	Sell	21,600 -1,500	-6%	-$11.6K	﹤0.01%	1612
2025 Q4	$204K	Buy	+23,100	New	+$127K	﹤0.01%	1657
2019 Q1	–	Sell	-94,400	Closed	-$2.47M	–	1632
2018 Q4	$2.47M	Buy	+94,400	New	+$2.22M	0.01%	929
2014 Q2	–	Sell	-2,100	Closed	-$34K	–	1307
2014 Q1	$34K	Buy	+2,100	New	+$29.9K	﹤0.01%	1187

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Canada Pension Plan Investment Board's VNDA Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its Vanda Pharmaceuticals (VNDA) stake by 6.9% in Q2 2026, selling an estimated $9.8K and leaving 20,100 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #1655.

Canada Pension Plan Investment Board first reported a position in VNDA in Q1 2014 and has held it in 5 quarters since. The position peaked at $2.47M in Q4 2018. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

Canada Pension Plan Investment Board held 20,100 shares of Vanda Pharmaceuticals worth $123K as of Q2 2026.
Canada Pension Plan Investment Board sold 1,500 Vanda Pharmaceuticals shares in Q2 2026, an estimated $9.8K.
Vanda Pharmaceuticals made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1655 holding.
Canada Pension Plan Investment Board first reported a position in Vanda Pharmaceuticals in Q1 2014 and has held it in 5 quarters since.
Canada Pension Plan Investment Board's Vanda Pharmaceuticals position peaked at $2.47M in Q4 2018.
172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.